Structural Genomics Consortium

Analysis

Structural Genomics Consortium is a registered charity in England and Wales, based in London. It was registered in May 2003, 23 years ago. Its declared purposes cover education/training and the advancement of health or saving of lives, which this site groups under health and saving lives. Legally it is a charitable company (Companies House number 04714553). It says it makes grants to organisations and sponsors or undertakes research.

In the financial year ending June 2025, Structural Genomics Consortium reported income of £4.7m and spending of £5.1m, spending 109% of what it took in. Across the 5 years on record, from June 2021 to June 2025, income fell from £10.3m to £4.7m (-54%), an average of -18% a year. The sharpest change came in the year to June 2025, when income rose by 33607%. Over the whole period it spent 99% of the income it received.

Among 24,651 England and Wales charities whose main cause is health and saving lives and that reported income, Structural Genomics Consortium sits at the 96th percentile: it is larger than about 96% of them. Against every charity in England and Wales with reported income it ranks in the 98th percentile. Charities of a similar size with the same main cause include The Bridge Project (£4.7m), Age UK Coventry and Warwickshire (£4.7m) and Four Paws (£4.7m).

In its latest detailed accounts, income came from donations and legacies 100%. Charitable activities took 98% of spending and raising funds 0.0%. Grants to other organisations totalled £3.7m. Reserves of £3.5m would cover about 8 months of spending at that rate.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.